Physician

Ross Wopat, M.D.

According to 2025 Medicare claims, Ross Wopat, M.D. (NPI: 1477812915) practices urology in the Albany, OR market, with the plurality of this provider's patient population coming from Linn, OR. This provider's primary affiliated billing organization is ALBANY GENERAL HOSPTIAL (NPI: 1861755902; TIN: 930110095) and primary practice location at 97321-1700.

Wopat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 335 traditional Medicare patients, billed 2,024 HCPCS/CPT codes, and received $97,610 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 867 prescription claims across 263 beneficiaries totaling $63,546 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 101 claims. Open Payments data shows 13 records totaling $532. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $9,778 to $97,610. Similarly, Part D prescription costs have risen steadily, from $4,062 to $63,546. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	52	178	$9,778
2018	162	1,997	$62,250
2019	209	1,209	$57,710
2020	275	1,776	$86,587
2021	345	3,053	$135,263
2022	367	3,241	$129,277
2023	321	3,655	$107,918
2024	335	2,024	$97,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	34	$4,062
2016	51	80	$1,444
2017	47	86	$2,142
2018	192	745	$23,964
2019	194	949	$37,688
2020	223	911	$51,811
2021	271	1,056	$47,232
2022	250	977	$43,551
2023	261	909	$39,983
2024	263	867	$63,546

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	15	$9,948
2019	N/R	40	$17,496
2020	N/R	26	$10,052
2021	N/R	27	$16,210
2022	N/R	37	$28,727
2023	N/R	63	$37,739
2024	N/R	101	$58,761

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	81	92	$167
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	108	137	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	139	165	$61
51798	Ultrasound measurement of bladder capacity after voiding	117	146	$8
81003	Automated urinalysis test	207	284	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	47	2,020	$30,338
Tamsulosin Hcl	Tamsulosin Hcl	339	22,266	$6,758
Trospium Chloride Er	Trospium Chloride	25	990	$3,958
Trospium Chloride	Trospium Chloride	39	1,710	$3,183
Finasteride	Finasteride	164	12,241	$2,615

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	72	$49,514
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	29	$9,247

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$532	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ross Wopat, M.D.?

Tedicare shows public-source Medicare data for Ross Wopat, M.D. (NPI 1477812915), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ross Wopat, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ross Wopat, M.D.?

Ross Wopat, M.D. is linked to ALBANY GENERAL HOSPTIAL (billing NPI 1861755902) in the available physician profile data.

Does Ross Wopat, M.D. have Open Payments data?

Ross Wopat, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.